Indication

Malignant neoplasm of fallopian tube

A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end. Read more about Malignant neoplasm of fallopian tube

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Malignant neoplasm of fallopian tube therapies.

Showing 1–1 of 1 drugs

LIFYORLI (relacorilant)

GLUCOCORTICOID RECEPTOR ANTAGONISTS·MALIGNANT NEOPLASM OF FALLOPIAN TUBE·+2
CORCEPT THERAPE
Filter & compare in the drug finder →Opens the drug finder with Malignant neoplasm of fallopian tube preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant neoplasm of fallopian tube.

A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end.

Predominantly affecting postmenopausal women, it shares biological, clinical, and staging characteristics with epithelial ovarian and primary peritoneal cancers.

Pathophysiologically, high-grade serous carcinoma accounts for the majority of cases and frequently harbors alterations in TP53 and pathogenic BRCA mutations.

Clinical manifestations are often subtle or nonspecific, but advanced disease may present with abdominal distension, pelvic pain, abnormal vaginal bleeding or profuse watery discharge, and a pelvic mass.

Personalize your experience

Follow Malignant neoplasm of fallopian tube and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it